BEAM Bulls-eye chart highlighting the R&D landscape for GLP-1 drugs
We may use third-party Service Providers to provide better improvement of our Service
Over the 80-week trial period, participants in the highest 12mg dose group achieved an average weight loss of 28.3% (approximately 70.3 lbs), while the 9mg group lost 25.9% (approximately 64.4 lbs), and the 4mg group lost 19.0% (approximately 47.2 lbs), compared to just 2.2% for the placebo group
At-home health testing to help members track a set of 17 biomarkers associated with long-term health, which include: ApoB & Lp(a): Newer heart-disease predictors not often tested by PCPs HbA1c: The gold standard for monitoring blood sugar control, early identification of prediabetes and prevention and management of diabetes hs-CRP: A key predictor of silent inflammation that can increase heart disease and stroke risk DHEA-S, Testosterone, Estradiol: Hormonal balance and resilience that change with age Vitamin D and B12: Important for metabolism and longevity, yet often needing supplementation Behavioral support through Nooms digital longevity companion Disclaimer: Noom Microdose GLP-1Rx Program involves healthy diet, exercise, biomarker monitoring, medication (when appropriate) and support
The foundation you build with proper nutrition, hydration, and side effect management pays dividends throughout the longer journey
